VERNE WEBSTER: Open Payments
NPI 1932163920 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 35 payments from 15 companies in 2025. Trend: 2023 $1,300 · 2024 $1,294 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $170 |
| Indivior Inc. | 4 | $141 |
| ABBVIE INC. | 4 | $65 |
| Alkermes, Inc. | 2 | $61 |
| Exact Sciences Corporation | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Novo Nordisk Inc | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $31 |
| Dexcom, Inc. | 1 | $27 |
Products named: CAPLYTA, SUBLOCADE, VIVITROL, The Cologuard Plus Collection Kit, Ozempic, UBRELVY, JOURNAVX, XIFAXAN.
Industry payments across AL — which companies pay providers there.
